Arkin Holdings

8 stories about Arkin Holdings
Guy Katsovich Nadav Shimoni

Nurturing digital health innovation: New Israeli program steps in to address startup decline

The program offers early-stage investment of up to $500,000 through a SAFE model, with Arkin Digital Health and Fusion aiming to invest in 10 new startups this year
Nadav Shimoni Arkin

Arkin Holdings: “I’m actually afraid we are not at the bottom yet” of the tech crisis

27.11.22|Elihay Vidal, James Spiro
Dr. Nadav Shimoni, Managing Director of Arkin Digital Health, joined CTech for its VC Survey series to consider how 2023 will look in the investment space.
Nadav Shimoni Arkin

Arkin Holdings is going all-in on digital health

04.04.22|James Spiro
“For us, digital health was at the beginning a lot of hype with buzzwords, but over the years the family essentially decided that it is a must,” Head of Digital Health Investments at Arkin Holdings, Dr. Nadav Shimoni, told CTech
נדב שמעוני Arkin Holdings

Digital health startups facing rapidly transforming business models in 2022

16.01.22|Nadav Shimoni
“It is more important than ever for digital health startups to have an in-depth understanding of the market dynamics and tackle a real business problem,” writes Nadav Shimoni of Arkin Holdings
נדב שמעוני Arkin Holdings

Nadav Shimoni, Arkin Holdings: We are looking for products that solve a real unmet need

06.12.21|Elihay Vidal
Speaking to CTech as part of a special investor survey, Nadav Shimoni, Head of Digital Health at Arkin Holdings, claimed that “high wages in tech are very harmful, as it reduces the number of people that stay long enough to develop their skills and contribute to a company”
פיני אורבך ואלון לזרוס ארקין ביו קפיטל

Arkin Holdings raises $270 million for new biotech fund

27.10.21|Meir Orbach
The new fund, which will be named Arkin Bio-Capital, intends to invest in 8-10 companies that are developing innovative medicine and plan on going public in the near future
ניר ארקין מנכ"ל קבוצת ארקין

Arkin Holdings turns focus to digital health, eyeing investments in early-stage startups

25.01.21|Golan Hazani
With $1.5 billion in assets under management over four funds, the Israeli company is a leading investor in the life sciences and pharmaceutical sectors